TheraBionic P1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

77 results for “TheraBionic P1”

Trials

View all 41 →

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

198 participants · First posted Aug 12, 2025

Not yet recruiting

Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression

24 participants · First posted Jun 29, 2026

A Study of the TheraBionic P1 Device in Breast Cancer

24 participants · First posted Oct 20, 2025

Drugs

View all 24 →

GX-P1

P1-E01

NeoTCR P1

Organizations

Therabionic, Inc.

United States

News

View all 11 →

Karmanos Cancer Institute First to Prescribe FDA-Approved TheraBionic P1 for Advanced Liver Cancer

Sutro Biopharma Initiates Pivotal Trial of Luvelta for Pediatric CBF/GLIS AML

Sutro Biopharma Initiates Pivotal Trial of Luvelta for Pediatric CBF/GLIS AML

Page 1 of 8